Sun Pharmaceutical Industries Ltd

Sun Pharma to buy remaining 34% of Taro for $592M

14 August, 2012

Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has reached an agreement to buy out the minority shareholders of New York Stock Exchange-listed Taro Pharmaceutical Industries and thereby take it private in a deal that would cost the Mumbai-based firm as much as $592 million (Rs 3,250 crore). Coupled with Sun Pharma’s earlier investments, the Taro deal translates into the largest acquisition by an Indian healthcare firm (within India or overseas) till date.


Leave Your Comment
Sun Pharma scraps plan to take NYSE-listed Taro private

Sun Pharma scraps plan to take NYSE-listed Taro private

TEAM VCC 5 years ago
Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has terminated a proposed merger agreement with New York Stock Exchange-listed Taro Pharmaceutical Industries,...
Sun Pharma to acquire Nasdaq-listed DUSA Pharma for $230M

Sun Pharma to acquire Nasdaq-listed DUSA Pharma for $230M

TEAM VCC 5 years ago
Mumbai-based Sun Pharma Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has struck another large overseas acquisition to buy NASDAQ-listed dermatology company DUSA Pharmaceuticals,...
Takeover Battle Ends: Sun Pharma Takes Controlling Stake In Taro

Takeover Battle Ends: Sun Pharma Takes Controlling Stake In Taro

Reghu Balakrishnan 7 years ago
Putting an end to the long takeover battle between with Israeli firm Taro Pharmaceuticals, Sun Pharmaceuticals has completed the acquisition of controlling stake in Taro...
No Comments

Sun Pharma to buy remaining 34% of Taro for $592M

Powered by WordPress.com VIP